Figure 6 from Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer
<p>MPZL3 loss enhances cisplatin and olaparib resistance in OVCAR4 cells. <b>A,</b> Dose–response curves were derived from cell viability assays (FluoReporter dsDNA quantification) of OVCAR4 cells expressing scr control or MPZL3 shRNAs (<i>n</i> = 4, mean ± SEM). <b&...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|